NCT05769127

Brief Summary

Type 2 diabetes mellitus is one of the fastest growing public health problems in developed and developing countries and imposes a large financial burden on health-care systems. Preventing, delaying, and managing diabetes should be a priority for health-care systems. Nationally, 38% of adults have prediabetes, with more than 80% of people with prediabetes being unaware of their condition. In Maryland, an estimated 10.5% of adults report prediabetes, and 33.7% of Baltimore City residents have obesity, an important risk factor for prediabetes. The BMDRP aims to increase the capacity of BMDRP hospitals and community partners to offer DPP and DSMT directly in communities and will also increase the number of referrals into these programs. Successful enrollment and completion of DPP has demonstrated reduced risk of developing type 2 diabetes for individuals with pre-diabetes. However, limited data exist on changes in body composition and liver fat in individuals completing DPP. Individuals with pre-diabetes often have obesity and non-alcoholic fatty liver disease. We will evaluate for changes in body fat and liver fat in individuals completing the DPP program.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2023

Typical duration for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 15, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

April 26, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2025

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

2.1 years

First QC Date

February 22, 2023

Last Update Submit

June 10, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Enrollees into DPP and DSMT

    Measure enrolled participants in DPP or DSMT programs

    end of calendar year enrollment, yearly for 3 years

  • Change in body weight for DPP participants

    Change in weight from baseline to 12 months after participating in DPP lifestyle intervention

    12 months

Secondary Outcomes (3)

  • Change in diabetes control for DSMT participants

    12 months

  • change in body composition in DPP participants

    12 months

  • change in liver elastography in DPP participants

    12 months

Study Arms (1)

Intervention

EXPERIMENTAL

All subjects participating in the diabetes prevention program will be offered body composition analysis and liver fat analysis, before, during, and after the lifestyle intervention

Other: Diabetes Prevention Program (DPP), Diabetes Self-Management Training (DSMT)

Interventions

DPP lifestyle intervention program DSMT education on diabetes and lifestyle changes

Intervention

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Qualify for DPP with a diagnosis of pre-diabetes and elevated BMI (≥25 kg/m2 , ≥23kg/m2 if Asian)
  • For DSMT, individuals with type 2 diabetes

You may not qualify if:

  • \- Normoglycemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland Center for Diabetes and Endocrinology

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Diabetes MellitusGlucose IntoleranceFatty LiverBody Weight Changes

Interventions

dentin sialophosphoprotein

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemiaLiver DiseasesDigestive System DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

February 22, 2023

First Posted

March 15, 2023

Study Start

April 26, 2023

Primary Completion

June 10, 2025

Study Completion

June 10, 2025

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations